$ADN
ADVENT TECHNOLOGIES HOLDINGS, INC. Stock $adn

$adn Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000182912622019214 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$1.957M	$2.399M	$1.674M
YoY Change	-32.57%	43.31%	642.64%
Cost Of Revenue	$2.455M	$2.339M	$1.646M
YoY Change	-10.52%	42.12%	1719.0%
Gross Profit	-$498.0K	$60.00K	$28.22K
YoY Change	-414.5%	112.64%	-79.09%
Gross Profit Margin	-25.45%	2.5%	1.69%
Selling, General & Admin	$9.258M	$8.203M	$13.04M
YoY Change	-35.34%	-37.1%	1370.81%
% of Gross Profit		13671.67%	46215.58%
Research & Development	$2.458M	$2.547M	$893.2K
YoY Change	24.17%	185.15%	2273.05%
% of Gross Profit		4245.0%	3165.52%
Depreciation & Amortization	$651.0K	$300.0K	$309.7K
YoY Change	-9.25%	-3.14%
% of Gross Profit		500.0%	1097.67%
Operating Expenses	$11.72M	$10.75M	$13.93M
YoY Change	-28.11%	-22.85%	1407.56%
Operating Profit	-$50.08M	-$11.09M	-$13.71M
YoY Change	200.63%	-19.08%	1672.73%
Interest Expense	$21.00K	-$33.00K	-$28.80K
YoY Change	-132.22%	14.58%	-172.0%
% of Operating Profit
Other Income/Expense, Net	$4.000K	$1.000K	-$15.96K
YoY Change	-106.4%	-106.27%	-151.39%
Pretax Income	-$47.93M	-$12.04M	-$11.33M
YoY Change	385.26%	6.22%	1406.9%
Income Tax	-$307.0K	-$567.0K	-$50.94K
% Of Pretax Income
Net Earnings	-$47.63M	-$11.47M	-$11.28M
YoY Change	428.82%	1.67%	1406.34%
Net Earnings / Revenue	-2433.57%	-478.03%	-673.82%
Basic Earnings Per Share	-$0.92	-$0.22	-$0.23
Diluted Earnings Per Share	-$0.92	-$0.22	-$0.23
COMMON SHARES
Basic Shares Outstanding	51.72M shares	51.66M shares	48.33M
Diluted Shares Outstanding	51.72M shares	51.66M shares	48.33M

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$32.87M	$42.45M	$92.49M
YoY Change	-58.79%	-54.11%	92392.37%
Cash & Equivalents	$32.87M	$42.45M	$92.49M
Short-Term Investments
Other Short-Term Assets	$2.292M	$3.408M	$3.767M
YoY Change	-51.57%	-9.53%
Inventory	$12.62M	$10.93M	$5.599M
Prepaid Expenses	$688.0K	$1.657M	$1.823M
Receivables	$979.0K	$1.987M	$6.506M
Other Receivables	$2.158M	$3.099M	$1.424M
Total Short-Term Assets	$49.50M	$61.35M	$108.4M
YoY Change	-49.15%	-43.39%	108264.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.94M	$9.745M	$7.883M
YoY Change	108.95%	23.62%
Goodwill	$5.742M	$30.03M	$29.40M
YoY Change	-80.86%	2.15%
Intangibles	$6.062M	$21.34M
YoY Change	-74.03%
Long-Term Investments
YoY Change
Other Assets	$5.971M	$2.918M	$3.435M
YoY Change	141.22%	-15.05%	-97.77%
Total Long-Term Assets	$40.09M	$66.15M	$65.60M
YoY Change	-38.96%	0.84%	-57.35%
TOTAL ASSETS
Total Short-Term Assets	$49.50M	$61.35M	$108.4M
Total Long-Term Assets	$40.09M	$66.15M	$65.60M
Total Assets	$89.59M	$127.5M	$174.0M
YoY Change	-45.05%	-26.71%	13.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.680M	$3.630M	$5.523M
YoY Change	-3.25%	-34.27%	5422.62%
Accrued Expenses	$1.522M	$1.719M	$7.596M
YoY Change	-74.22%	-77.37%
Deferred Revenue	$1.019M	$1.221M	$28.83K
YoY Change	-7.36%	4134.88%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$13.67M	$14.02M	$15.41M
YoY Change	-27.58%	-9.01%	542.1%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$852.0K	$600.0K	$18.66M
YoY Change	-14.43%	-96.79%	142.39%
Total Long-Term Liabilities	$11.77M	$6.075M	$18.66M
YoY Change	-15.65%	-67.45%	142.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.67M	$14.02M	$15.41M
Total Long-Term Liabilities	$11.77M	$6.075M	$18.66M
Total Liabilities	$25.44M	$20.10M	$37.83M
YoY Change	-22.51%	-46.88%	270.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$107.8M	-$60.14M	-$24.42M
YoY Change	222.4%	146.27%
Common Stock	$5.000K	$5.000K	$5.125K
YoY Change	-2.44%	-2.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$64.15M	$107.4M	$136.1M
YoY Change
Total Liabilities & Shareholders Equity	$89.59M	$127.5M	$174.0M
YoY Change	-45.05%	-26.71%	13.04%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$47.63M	-$11.47M	-$11.28M
YoY Change	428.82%	1.67%	1406.34%
Depreciation, Depletion And Amortization	$651.0K	$300.0K	$309.7K
YoY Change	-9.25%	-3.14%
Cash From Operating Activities	$41.00K	-$2.810M	-$8.459M
YoY Change	-100.37%	-66.78%	1221.7%
INVESTING ACTIVITIES
Capital Expenditures	$7.978M	-$872.0K	-$1.711M
YoY Change	-723.46%	-49.03%	-5802.43%
Acquisitions
YoY Change
Other Investing Activities	-$2.554M	$9.000K	-$12.89M
YoY Change	827.58%	-100.07%	1242.85%
Cash From Investing Activities	-$10.53M	-$863.0K	-$14.60M
YoY Change	577.32%	-94.09%	1421.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.000K	-41.00K	-4.110K
YoY Change	-79.55%	897.57%	-100.26%
NET CHANGE
Cash From Operating Activities	41.00K	-2.810M	-8.459M
Cash From Investing Activities	-10.53M	-863.0K	-14.60M
Cash From Financing Activities	1.000K	-41.00K	-4.110K
Net Change In Cash	-10.49M	-3.714M	-23.07M
YoY Change	-17.38%	-83.9%	115225.55%
FREE CASH FLOW
Cash From Operating Activities	$41.00K	-$2.810M	-$8.459M
Capital Expenditures	$7.978M	-$872.0K	-$1.711M
Free Cash Flow	-$7.937M	-$1.938M	-$6.748M
YoY Change	-19.56%	-71.28%	907.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Address Address Line1 EntityAddressAddressLine1	200 Clarendon Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Boston
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02116
	dei	City Area Code CityAreaCode	(617)
	dei	Local Phone Number LocalPhoneNumber	655-6000
	dei	Entity Registrant Name EntityRegistrantName	Advent Technologies Holdings, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-0982969
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38742
	dei	Entity Central Index Key EntityCentralIndexKey	0001744494
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	adn	Stockholders Equity Recapitalization Of Reporting Entity StockholdersEquityRecapitalizationOfReportingEntity		usd
CY2021Q4	adn	Contractual Obligation Quantity Pieces Year Two ContractualObligationQuantityPiecesYearTwo		electrodes
	dei	Document Type DocumentType	10-Q
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	51717720	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42446000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	79764000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1987000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3139000	usd
CY2022Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	914000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1617000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	10933000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	6958000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5065000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5873000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	61345000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	97351000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	30030000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	30030000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	21338000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23344000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9745000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8585000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2918000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2475000	usd
CY2022Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1827000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1246000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	291000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	-0	usd
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	66149000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	65680000	usd
CY2022Q3	us-gaap	Assets Assets	127494000	usd
CY2021Q4	us-gaap	Assets Assets	163031000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3630000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4837000	usd
CY2022Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3125000	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	10373000	usd
CY2022Q3	us-gaap	Deferred Income Current DeferredIncomeCurrent	906000	usd
CY2021Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent	205000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1221000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1118000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8097000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12515000	usd
CY2022Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	168000	usd
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	196000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	14022000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18871000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2159000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2500000	usd
CY2022Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	96000	usd
CY2021Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	90000	usd
CY2022Q3	us-gaap	Deferred Income Noncurrent DeferredIncomeNoncurrent	95000	usd
CY2021Q4	us-gaap	Deferred Income Noncurrent DeferredIncomeNoncurrent	-0	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	600000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	996000	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	6075000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	13959000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	20097000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	32830000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	110000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	110000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51717720	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51717720	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51253591	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51253591	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	5000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	5000	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	-0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	-0	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	171842000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	164894000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4313000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1273000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-60137000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33425000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	107397000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	130201000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	127494000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	163031000	usd
CY2022Q3	us-gaap	Revenues Revenues	2399000	usd
CY2021Q3	us-gaap	Revenues Revenues	1674000	usd
	us-gaap	Revenues Revenues	5880000	usd
	us-gaap	Revenues Revenues	4167000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2339000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1646000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6126000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2663000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	60000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	28000	usd
	us-gaap	Gross Profit GrossProfit	-246000	usd
	us-gaap	Gross Profit GrossProfit	1504000	usd
CY2022Q3	adn	Income From Grants IncomeFromGrants	294000	usd
CY2021Q3	adn	Income From Grants IncomeFromGrants	508000	usd
	adn	Income From Grants IncomeFromGrants	1011000	usd
	adn	Income From Grants IncomeFromGrants	632000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2547000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	893000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7338000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1561000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8203000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13041000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26657000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	27558000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	696000	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	310000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2113000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	467000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11092000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-13708000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-35343000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-27450000	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	911000	usd
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2422000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-7248000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-15833000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-0	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-14000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-27000	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-33000	usd
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-15000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-51000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2000	usd
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51660133	shares
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-16000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-220000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	78000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12035000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11331000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28375000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11568000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-567000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-51000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1663000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-51000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-11468000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-11280000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-26712000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11517000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51660133	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48325164	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51465004	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43982039	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48325164	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51465004	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43982039	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-11468000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-11280000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-26712000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11517000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1181000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-541000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3040000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-829000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1181000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-541000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3040000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-829000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12649000	usd
	adn	Proceeds From Shares Issued In Business Combination ProceedsFromSharesIssuedInBusinessCombination	141121000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11821000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-29752000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12346000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	118184000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1862000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-11468000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1181000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	107397000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	130201000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6948000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-26712000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3040000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	107397000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	106654000	usd
CY2021Q3	adn	Share Capital Increase ShareCapitalIncrease	37924000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3376000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-11280000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-541000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	136133000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1794000	usd
	adn	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Before Recapitalization Transactions StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestBeforeRecapitalizationTransactions	-1794000	usd
	adn	Stock Issued During Period Value Acquisitions And Private Investment In Public Equity StockIssuedDuringPeriodValueAcquisitionsAndPrivateInvestmentInPublicEquity	108008000	usd
	adn	Share Capital Increase From Warrants Exercise ShareCapitalIncreaseFromWarrantsExercise	262000	usd
	adn	Share Capital Increase ShareCapitalIncrease	37924000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4079000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11517000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-829000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	136133000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-32166000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-24690000	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	3549000	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	2659000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	117000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
	adn	Payments To Acquire Fixed Assets PaymentsToAcquireFixedAssets	0	usd
	adn	Payments To Acquire Fixed Assets PaymentsToAcquireFixedAssets	1918000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	19425000	usd
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	319000	usd
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3985000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24002000	usd
	adn	Proceeds From Shares Issued In Business Combination ProceedsFromSharesIssuedInBusinessCombination	-0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	262000	usd
	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_804_eus-gaap--BasisOfAccounting_zUhW9uytRkvb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; padding-right: 0.8pt"><span style="font-size: 10pt"><b>1.</b></span></td> <td style="padding-right: 0.8pt; text-align: justify"><span style="font-size: 10pt"><b><span id="xdx_82D_z1yOPWDgn8l9">Basis of presentation</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Overview</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 4, 2021 (“Closing Date”), AMCI Acquisition Corp. (“AMCI”), consummated the previously announced business combination (the “Business Combination”) pursuant to that certain merger agreement (the “Agreement and Plan of Merger”), dated October 12, 2020, by and among AMCI, AMCI Merger Sub Corp., a Delaware corporation and newly formed wholly-owned subsidiary of AMCI (“Merger Sub”), AMCI Sponsor LLC (the “Sponsor”), solely in the capacity as the representative from and after the effective time of the Business Combination for the stockholders of AMCI, Advent Technologies, Inc., a Delaware corporation (“Legacy Advent”), and Vassilios Gregoriou, solely in his capacity as the representative from and after the effective time for the Legacy Advent stockholders (the “Seller Representative”), as amended by Amendment No. 1 and Amendment No. 2 to the Agreement and Plan of Merger, dated as of October 19, 2020 and December 31, 2020, respectively, by and among AMCI, Merger Sub, Sponsor, Legacy Advent, and Seller Representative. In connection with the closing of the Business Combination (the “Closing”), AMCI acquired <span id="xdx_902_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_c20210204__us-gaap--BusinessAcquisitionAxis__custom--AMCIAcquisitionCorpMember_zP1PXMclIy8d" title="Acquired percentage">100</span>% of the stock of Legacy Advent (as it existed immediately prior to the Closing) and its subsidiaries.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On the Closing Date, and in connection with the closing of the Business Combination, AMCI changed its name to Advent Technologies Holdings, Inc. (the “Company” or “Advent”). Legacy Advent was deemed the accounting acquirer in the Business Combination based on an analysis of the criteria outlined in Accounting Standards Codification (“ASC”) 805. This determination was primarily based on Legacy Advent’s stockholders prior to the Business Combination having a majority of the voting interests in the combined company, Legacy Advent’s operations comprising the ongoing operations of the combined company, Legacy Advent’s board of directors comprising a majority of the board of directors of the combined company, and Legacy Advent’s senior management comprising the senior management of the combined company. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Legacy Advent issuing stock for the net assets of AMCI, accompanied by a recapitalization. The net assets of AMCI are stated at historical cost, with no goodwill or other intangible assets recorded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">While AMCI was the legal acquirer in the Business Combination, because Legacy Advent was deemed the accounting acquirer, the historical financial statements of Legacy Advent became the historical financial statements of the combined company, upon the consummation of the Business Combination. As a result, the consolidated financial statements included in this report reflect (i) the historical operating results of Legacy Advent prior to the Business Combination; (ii) the results of the Company (combined results of AMCI and Legacy Advent) following the closing of the Business Combination; (iii) the assets and liabilities of Legacy Advent at their historical cost; and (iv) Company’s equity structure for all periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with guidance applicable to these circumstances, the equity structure has been restated in all comparative periods up to the Closing Date, to reflect the number of shares of the Company’s common stock, $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_c20210204__us-gaap--BusinessAcquisitionAxis__custom--AMCIAcquisitionCorpMember_pdd" title="Common stock, par value (in dollars per share)">0.0001</span> par value per share, issued to Legacy Advent’s stockholders in connection with the recapitalization transaction. As such, the shares and corresponding capital amounts and earnings per share related to Legacy Advent Preferred Stock (“Preferred Series A” and “Preferred Series Seed”) and Legacy Advent common stock prior to the Business Combination have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination Agreement. Activity within the statement of changes in stockholders’ equity / (deficit) for the issuances of Legacy Advent’s Preferred Stock, were also retroactively converted to Legacy Advent common stock (Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 18, 2021, Advent Technologies, Inc. entered into a Membership Interest Purchase Agreement with Bren-Tronics, Inc. (“Bren-Tronics”) and UltraCell, LLC (“UltraCell”), a Delaware limited liability company and a direct wholly owned subsidiary of Bren-Tronics (the “UltraCell Purchase Agreement”). See Note 3 “Business Combination” for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">UltraCell LLC was renamed to Advent Technologies LLC following its acquisition by the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2021, the Company entered into a Share Purchase Agreement (the “Purchase Agreement”), with F.E.R. fischer Edelstahlrohre GmbH, a limited liability company incorporated under the Laws of Germany (the “Seller”) to acquire all of the issued and outstanding equity interests in SerEnergy A/S, a Danish stock corporation and a wholly-owned subsidiary of the Seller (“SerEnergy”) and fischer eco solutions GmbH, a German limited liability company and a wholly-owned subsidiary of the Seller (“FES”) together with certain outstanding shareholder loan receivables. See Note 3 “Business Combination” for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">SerEnergy and FES were renamed to Advent Technologies A/S and Advent Technologies GmbH, respectively, following their acquisition by the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advent Technologies Holdings, Inc. and its subsidiaries (collectively referred to as “Advent”, the “Company,” we,” “us” and “our”) is an advanced materials and technology development company operating in the fuel cell and hydrogen technology space. Advent develops, manufactures and assembles the critical components that determine the performance of hydrogen fuel cells and other energy systems. To date, Advent’s principal operations have been to develop and manufacture Membrane Electrode Assembly (MEA) and to design fuel cell stacks and complete fuel cell systems for a range of customers in the stationary power, portable power, automotive, aviation, energy storage and sensor markets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advent has its headquarters in Boston, Massachusetts, a product development facility in Livermore, California, and production facilities in Greece, Denmark, and Germany and sales and warehousing facilities in the Philippines.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The unaudited condensed consolidated financial statements of the Company have been prepared to reflect the consolidation of the companies listed below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--SubsidiariesInConsolidationTableTextBlock_z6f0u407aSrd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of presentation (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="display: none; text-align: justify; text-indent: 0pt; padding-left: 0pt">Subsidiaries in Consolidation</td><td> </td> <td style="text-align: center; text-indent: 0pt; padding-left: 0pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: center">Country of</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ownership Interest</td><td style="padding-bottom: 1pt; font-size: 12pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Statements of Operations</td><td style="padding-bottom: 1pt; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Company Name</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Incorporation</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Direct</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Indirect</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 38%; text-align: justify; text-indent: 0pt; padding-left: 0pt"><span id="xdx_908_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesIncMember_zwGTsWyS0dVl" title="Company Name">Advent Technologies, Inc.</span></td><td style="width: 1%"> </td> <td id="xdx_98C_ecustom--SubsidiaryPlaceOfIncorporation_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesIncMember" style="width: 11%; text-align: center; text-indent: 0pt; padding-left: 0pt" title="Country of Incorporation">USA</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 7%; text-align: right"><span id="xdx_90C_ecustom--OwnershipPercentageInSubsdaries_iI_dp_c20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesIncMember__srt--OwnershipAxis__custom--DirectOwnershipMember_zrHZjn1Dipi2" title="Ownership Interest">100</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_ecustom--OwnershipPercentageInSubsdaries_iI_dp0_c20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesIncMember__srt--OwnershipAxis__custom--IndirectOwnershipMember_zIwx4zF0u1Wi" style="width: 7%; text-align: right" title="Ownership Interest">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: center"> </td><td id="xdx_98A_ecustom--StatementsOfOperationsDate_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesIncMember_zmVmg061dvV1" style="width: 12%; text-align: center" title="Statements of Operations date"><span style="font-size: 10pt">01/01 – 9/30</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: center"> </td><td id="xdx_98F_ecustom--StatementsOfOperationsDate_c20210101__20210930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesIncMember_zeW3JLi8HX2" style="width: 12%; text-align: center" title="Statements of Operations date"><span style="font-size: 10pt">01/01 – 9/30</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; text-indent: 0pt; padding-left: 0pt"><span id="xdx_900_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesSAMember_zY9TKKpgFOlh" title="Company Name">Advent Technologies S.A.</span></td><td> </td> <td id="xdx_98D_ecustom--SubsidiaryPlaceOfIncorporation_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesSAMember" style="text-align: center; text-indent: 0pt; padding-left: 0pt" title="Country of Incorporation">Greece</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--OwnershipPercentageInSubsdaries_iI_dp_c20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesSAMember__srt--OwnershipAxis__custom--DirectOwnershipMember_zjYDhe9R7yha" style="text-align: right" title="Ownership Interest"><span style="-sec-ix-hidden: xdx2ixbrl0705">-</span></td><td style="text-align: left"/><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--OwnershipPercentageInSubsdaries_iI_dp0_c20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesSAMember__srt--OwnershipAxis__custom--IndirectOwnershipMember_zjzYVMTEN0e2" style="text-align: right" title="Ownership Interest">100</td><td style="text-align: left">% </td><td> </td> <td style="text-align: center"> </td><td id="xdx_987_ecustom--StatementsOfOperationsDate_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesSAMember" style="text-align: center" title="Statements of Operations date"><span style="font-size: 10pt">01/01 – 9/30</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td id="xdx_98C_ecustom--StatementsOfOperationsDate_c20210101__20210930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesSAMember_zF7xtWymaJdd" style="text-align: center" title="Statements of Operations date"><span style="font-size: 10pt">01/01 – 9/30</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; text-indent: 0pt; padding-left: 0pt"><span id="xdx_90D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesLLCMember_zJiZG29B8Eee" title="Company Name">Advent Technologies LLC</span></td><td> </td> <td id="xdx_981_ecustom--SubsidiaryPlaceOfIncorporation_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesLLCMember" style="text-align: center; text-indent: 0pt; padding-left: 0pt" title="Country of Incorporation">USA</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--OwnershipPercentageInSubsdaries_iI_dp0_c20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesLLCMember__srt--OwnershipAxis__custom--DirectOwnershipMember_zQAvweLPnSk6" style="text-align: right" title="Ownership Interest">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--OwnershipPercentageInSubsdaries_iI_dp_c20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesLLCMember__srt--OwnershipAxis__custom--IndirectOwnershipMember_zuUhhsvmzLt4" style="text-align: right" title="Ownership Interest">100</td><td style="text-align: left">%</td><td> </td> <td style="text-align: center"> </td><td id="xdx_985_ecustom--StatementsOfOperationsDate_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesLLCMember" style="text-align: center" title="Statements of Operations date"><span style="font-size: 10pt">01/01 – 9/30</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td id="xdx_987_ecustom--StatementsOfOperationsDate_c20210101__20210930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesLLCMember_zMX5TenYo156" style="text-align: center" title="Statements of Operations date"><span style="font-size: 10pt">02/19 – 9/30</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; text-indent: 0pt; padding-left: 0pt"><span id="xdx_90F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesGmbHMember_z7nriHlUtLoi" title="Company Name">Advent Technologies GmbH</span></td><td> </td> <td id="xdx_984_ecustom--SubsidiaryPlaceOfIncorporation_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesGmbHMember" style="text-align: center; text-indent: 0pt; padding-left: 0pt" title="Country of Incorporation">Germany</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--OwnershipPercentageInSubsdaries_iI_dp_c20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesGmbHMember__srt--OwnershipAxis__custom--DirectOwnershipMember_zOPq2sZMdiu3" style="text-align: right" title="Ownership Interest">100</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--OwnershipPercentageInSubsdaries_iI_dp0_c20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesGmbHMember__srt--OwnershipAxis__custom--IndirectOwnershipMember_zIq6oQykWbHb" style="text-align: right" title="Ownership Interest">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td id="xdx_98B_ecustom--StatementsOfOperationsDate_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesGmbHMember_zdKlgfrLx7wl" style="text-align: center" title="Statements of Operations date"><span style="font-size: 10pt">01/01 – 9/30</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td id="xdx_98B_ecustom--StatementsOfOperationsDate_c20210101__20210930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesGmbHMember_zhQXJFCXFWya" style="text-align: center" title="Statements of Operations date"><span style="font-size: 10pt">09/01 – 9/30</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; text-indent: 0pt; padding-left: 0pt"><span id="xdx_903_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesASMember_z83wXAUbDO2k" title="Company Name">Advent Technologies A/S</span></td><td> </td> <td id="xdx_98D_ecustom--SubsidiaryPlaceOfIncorporation_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesASMember" style="text-align: center; text-indent: 0pt; padding-left: 0pt" title="Country of Incorporation">Denmark</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--OwnershipPercentageInSubsdaries_iI_dp_c20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesASMember__srt--OwnershipAxis__custom--DirectOwnershipMember_zmEXUQ9LmIT2" style="text-align: right" title="Ownership Interest">100</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--OwnershipPercentageInSubsdaries_iI_dp0_c20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesASMember__srt--OwnershipAxis__custom--IndirectOwnershipMember_zU1yyEM7jY9g" style="text-align: right" title="Ownership Interest">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td id="xdx_987_ecustom--StatementsOfOperationsDate_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesASMember" style="text-align: center" title="Statements of Operations date"><span style="font-size: 10pt">01/01 – 9/30</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td id="xdx_988_ecustom--StatementsOfOperationsDate_c20210101__20210930__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesASMember_z3wYXUr2zhsl" style="text-align: center" title="Statements of Operations date"><span style="font-size: 10pt">09/01 – 9/30</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt"><span style="font-size: 10pt"><span id="xdx_903_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventGreenEnergyPhilippinesIncMember_zHajoWc2zrzg" title="Company Name">Advent Green Energy Philippines, Inc</span></span></td><td> </td> <td id="xdx_98C_ecustom--SubsidiaryPlaceOfIncorporation_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventGreenEnergyPhilippinesIncMember" style="text-align: center; text-indent: 0pt; padding-left: 0pt" title="Country of Incorporation">Philippines</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--OwnershipPercentageInSubsdaries_iI_dp0_c20220930__srt--ConsolidatedEntitiesAxis__custom--AdventGreenEnergyPhilippinesIncMember__srt--OwnershipAxis__custom--DirectOwnershipMember_zP3NZtgNuon3" style="text-align: right" title="Ownership Interest">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--OwnershipPercentageInSubsdaries_iI_dp_c20220930__srt--ConsolidatedEntitiesAxis__custom--AdventGreenEnergyPhilippinesIncMember__srt--OwnershipAxis__custom--IndirectOwnershipMember_z9bnF4Yg9xz8" style="text-align: right" title="Ownership Interest">100</td><td style="text-align: left">%</td><td> </td> <td style="text-align: center"> </td><td id="xdx_980_ecustom--StatementsOfOperationsDate_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AdventGreenEnergyPhilippinesIncMember" style="text-align: center" title="Statements of Operations date"><span style="font-size: 10pt">01/01 – 9/30</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td id="xdx_982_ecustom--StatementsOfOperationsDate_c20210101__20210930__srt--ConsolidatedEntitiesAxis__custom--AdventGreenEnergyPhilippinesIncMember_zUaHnnAHQYu8" style="text-align: center" title="Statements of Operations date"><span style="font-size: 10pt">09/01 – 9/30</span></td><td style="text-align: left"> </td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b><i>Unaudited Condensed Consolidated Financial Statements</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and pursuant to the regulations of the U.S. Securities and Exchange Commission (“SEC”). The unaudited financial information reflects, in the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial position, results of operations and cash flows for the periods indicated. The results reported for the interim period presented are not necessarily indicative of results that may be expected for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s audited consolidated financial statements as of and for the year ended December 31, 2021, included in the Annual Report on Form 10-K filed with the SEC on March 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Share and per share amounts are presented on a post-conversion basis for all periods presented, unless otherwise specified.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Going Concern</i></b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The unaudited condensed consolidated financial statements have been prepared by management, assuming that the Company will continue as a going concern and accordingly, these financial statements do not include any adjustments that may result in the event the Company is unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The management of the Company assesses the Company’s ability to continue as a going concern at each period end. The assessment evaluates whether there are conditions that give rise to substantial doubt to continue as a going concern within one year from the consolidated financial statements issuance date, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The management examines closely its operating results and its cash position and makes adjustments to its cash flow forecasts where necessary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Beginning in March 2020, the coronavirus (“COVID-19”) pandemic and the measures imposed to contain this pandemic have affected business and economic activity around the world. Since the COVID-19 outbreak, the Company has been closely monitoring and adopting all necessary measures to protect its employees and partners and to minimize as much as possible the business disruption caused by the pandemic. During 2021 and 2022, as a result of the mass vaccination schemes initiated around the world, the restrictive measures imposed by the governments began to be gradually lifted and the worldwide restrictions to mobility were relaxed, leading to increased economic activity and improved global macro-economic indicators.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management is closely monitoring the developments around COVID-19 and is constantly assessing its implications on the Company’s productivity, results of operations and financial position. At this stage, the Company maintains a strong financial position with its cash and cash equivalents amounting to $<span id="xdx_90E_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_dm_c20220930__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashEquivalentsMember_z9Ijy5JV6uL3">42.4 </span> million. Additionally, as of September 30, 2022, the Company reported a positive working capital of $<span id="xdx_905_ecustom--WorkingCapital_iI_pn3n3_dm_c20220930_zS7NIgdquAM2">47.3 </span>million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of the date of this Quarterly Report on Form 10-Q, the Company’s existing cash resources are sufficient to support planned operations for the next 12 months. As a result, management believes that the Company’s existing financial resources are sufficient to continue operating activities for at least one year past the issuance date of the consolidated financial statements.</p>
CY2022Q3	adn	Working Capital WorkingCapital	47300000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	-0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	113000	usd
	adn	State Refundable Deposit Repayment StateRefundableDepositRepayment	41000	usd
	adn	State Refundable Deposit Repayment StateRefundableDepositRepayment	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-41000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	141496000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-36192000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	92804000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1126000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-828000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	79764000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	516000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	42446000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	92492000	usd
	us-gaap	Interest Paid Net InterestPaidNet	16000	usd
	us-gaap	Interest Paid Net InterestPaidNet	-0	usd
	adn	Noncash Or Partial Noncash Transaction Stock Based Compensation NoncashOrPartialNoncashTransactionStockBasedCompensation	7747000	usd
	adn	Noncash Or Partial Noncash Transaction Stock Based Compensation NoncashOrPartialNoncashTransactionStockBasedCompensation	4079000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zb9c4m3mkKO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_867_z8dSwVRn2tS5">Use of Estimates</span> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. On an on-going basis, management evaluates the estimates and judgments, including those related to the selection of useful lives for tangible assets, expected future cash flows from long-lived assets to support impairment tests, the carrying value of goodwill, provisions necessary for accounts receivables and inventory write downs, provisions for legal disputes, and contingencies. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates under different assumptions and/or conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/>
	us-gaap	Derivatives Methods Of Accounting Nonhedging Derivatives DerivativesMethodsOfAccountingNonhedgingDerivatives	<p id="xdx_842_eus-gaap--DerivativesMethodsOfAccountingNonhedgingDerivatives_zhnoKo0pPP9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i><span id="xdx_86D_zwbbvLuRWHu2">Warrant Liability</span> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a result of the Business Combination, the Company assumed a warrant liability (the “Warrant Liability”) related to previously issued <span id="xdx_908_ecustom--ClassOfWarrantOrRightIssued_pip0_c20220101__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zdqLWQtKD56e" title="Warrants issued (in shares)">3,940,278</span> warrants, each exercisable to purchase one <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCRMnLQ9dvg2" style="display: none" title="Number of shares called by each warrant (in shares)">1</span> share of common stock at an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pip0_c20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhovK9seYmy4" title="Exercise price (in dollars per share)">11.50</span> per share, originally sold to AMCI Sponsor LLC (the “Sponsor”) in a private placement consummated in connection with AMCI’s initial public offering (the “Private Placement Warrants”) and the <span id="xdx_904_ecustom--ClassOfWarrantOrRightIssued_pip0_c20220101__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--WorkingCapitalWarrantsMember_zAlj5v4rtpo1" title="Warrants issued (in shares)">400,000</span> warrants, each exercisable to purchase one share of common stock at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pip0_c20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--WorkingCapitalWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zv5qJqhnT0y1" title="Exercise price (in dollars per share)">11.50</span> per share, converted from the Sponsor’s non-interest bearing loan to the Company of $<span id="xdx_90B_ecustom--NonInterestBearingLoan_pp0p0_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_z6WQNQgMfwNb" title="Non-interest bearing loan">400,000</span> in connection with the closing of the Business Combination (the “Working Capital Warrants”) (Note 13). The Private Placement Warrants and the Working Capital Warrants have substantially the same terms as the <span id="xdx_903_ecustom--ClassOfWarrantOrRightIssued_pip0_c20220101__20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_znx7ZfHYrWL1" title="Warrants issued (in shares)">22,029,279</span> warrants, each exercisable to purchase one <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pip0_c20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--WorkingCapitalWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVkBjNy4MmSg" style="display: none" title="Number of shares called by each warrant (in shares)">1</span> share of common stock at an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pip0_c20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSyOQmUhxJrl" title="Exercise price (in dollars per share)">11.50</span> per share, issued by AMCI in its initial public offering (the “Public Warrants”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following tables summarize the fair value of the Company’s assets and liabilities measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_pn3n3_zvF2HEgz5gtk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span id="xdx_8B9_zcbjclRVqLSj" style="display: none">Liabilities Measured at Fair Value on Recurring Basis</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; font-size: 12pt; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of September 30, 2022 (unaudited)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">(Amounts in thousands)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Unobservable Inputs<br/> (Level 3)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; font-weight: bold; text-indent: -0.125in">Assets</td><td style="font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: center"> </td><td style="font-size: 12pt"> </td><td style="font-size: 12pt"> </td> <td colspan="2" style="font-size: 12pt; text-align: center"> </td><td style="font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Available for sale financial asset</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsAssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFrBZvmVhFId" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Assets">291</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsAssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z4GHauQj4FA9" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Assets">291</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; font-size: 12pt; padding-bottom: 2.5pt; padding-left: 0.125in"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20220930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7PvDRgHI04a" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Liabilities">291</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zUqsswNOK6U7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Assets">291</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; font-size: 12pt; padding-left: 0.125in"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; font-weight: bold; padding-left: 0.125in">Liabilities</td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_c20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_znDU0B16b6r6" style="border-bottom: Black 1pt solid; text-align: right" title="Liabilities">3,125</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_c20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z4pKma26UT03" style="border-bottom: Black 1pt solid; text-align: right" title="Liabilities">3,125</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; font-size: 12pt; padding-bottom: 2.5pt; padding-left: 0.125in"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_c20220930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2NUsp5Pnt2k" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Liabilities">3,125</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_c20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zPLGbciqEOR6" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Liabilities">3,125</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; font-size: 12pt; text-indent: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in">(Amounts in thousands)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Unobservable Inputs<br/> (Level 3)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; font-weight: bold; text-indent: -0.125in">Liabilities</td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liability</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_c20211231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zaRUahuphGN4" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Liabilities">10,373</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zn5DfA4cx4Il" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Liabilities">10,373</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; font-size: 12pt; padding-bottom: 2.5pt; padding-left: 0.125in"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zJ8rCUNDW9fb" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Liabilities">10,373</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zj3buX9cYn3b" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Liabilities">10,373</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zCN0yfDgKPtj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2021, the Company did <span id="xdx_900_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_do_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z8BcJ3AxJEg2" title="Assets, Fair Value Disclosure">no</span>t hold any assets measured at fair value on a recurring basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying amounts of the Company’s remaining financial instruments reflected on the unaudited condensed consolidated balance sheets and which consist of cash and cash equivalents, accounts receivables, net, other current assets, trade and other payables, and other current liabilities, approximate their respective fair values due to their short-term nature.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Changes in the fair value of Level 3 assets and liabilities for the three and nine months ended September 30, 2022 and 2021 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_pn3n3_zawHm6sFPtG7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies,Fair value liabilities (Details)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; text-align: left; padding-left: 0.125in"><span style="display: none"><span id="xdx_8B4_zkfcHssAVOr6">Change in Fair Value of Warrant Liability</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="17" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Available for Sale Financial Asset</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0.125in; text-align: left; text-indent: -0.125in">(Amounts in thousands)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Three Months Ended September 30,<br/> 2022 (unaudited)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Three Months Ended September 30,<br/> 2021 (unaudited)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Nine Months Ended September 30,<br/> 2022 (unaudited)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Nine Months Ended September 30,<br/> 2021 (unaudited)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-indent: -0.125in; width: 52%; padding-left: 0.125in">Estimated fair value (beginning of period)</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_pn3n3_c20220701__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zC6tyGFcGJg" style="font: bold 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Estimated fair value asset at beginning balance">311</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_pn3n3_d0_c20210701__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zOTpWpU4guQg" style="font: bold 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Estimated fair value at beginning balance"> -</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_pn3n3_d0_c20220101__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_z1ZNDs8pHnVa" style="font: bold 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Estimated fair value at beginning balance">-</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><b>$</b></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_pn3n3_d0_c20210101__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zcvi0VlRb967" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Estimated fair value at beginning balance"> -</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; text-align: left; padding-left: 0.125in">Estimated fair value of available for sale financial asset acquired</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_pn3n3_d0_c20220701__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zmEHh6d307Ge" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Estimated fair value of available for sale financial asset acquired">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_pn3n3_d0_c20210701__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_z2CRdpgzLV2g" style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_pn3n3_c20220101__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zIlLkiyS4ldk" style="font: 10pt Times New Roman, Times, Serif; text-align: right">311</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_pn3n3_d0_c20210101__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_z4IePF0RhYYd" style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; text-align: left; padding-left: 0.125in">Foreign exchange fluctuations</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignExchangeFluctuations_iN_pn3n3_di_c20220701__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zJ5Akvtd4wOb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Foreign exchange fluctuations">(20</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignExchangeFluctuations_iN_pn3n3_di0_c20210701__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_z6Y0bRBm5zRh" style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignExchangeFluctuations_iN_pn3n3_di_c20220101__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zRMNVmXUALx8" style="font: 10pt Times New Roman, Times, Serif; text-align: right">(20</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignExchangeFluctuations_iN_pn3n3_di0_c20210101__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zmc959GoqI1j" style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in estimated fair value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_iN_pn3n3_di0_c20220701__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zVFqP9dqpNyk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in estimated fair value">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_iN_pn3n3_di0_c20210701__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_znDCvpPuhTte" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in estimated fair value">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_iN_pn3n3_di0_c20220101__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zdana9MC1o5k" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in estimated fair value">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_iN_pn3n3_di0_c20210101__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zAKIf5ZNGSt7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in estimated fair value">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in">Estimated fair value (end of period)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_pn3n3_c20220701__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zjZAc56gw5sa" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Estimated fair value at ending balance">291</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_pn3n3_d0_c20210701__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zQB7z5WalGd3" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Estimated fair value at ending balance">-</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_pn3n3_c20220101__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_ze8GJ9vHZ2bl" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Estimated fair value at ending balance">291</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_pn3n3_d0_c20210101__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zFbjfPfaCIW7" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Estimated fair value at ending balance">-</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrant Liability</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt">(Amounts in thousands)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended September 30,<br/> 2022 (unaudited)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Three Months Ended September 30,<br/> 2021 (unaudited)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Nine Months Ended September 30,<br/> 2022 (unaudited)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Nine Months Ended September 30,<br/> 2021 (unaudited)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">Estimated fair value (beginning of period)</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20220701__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zrrnfkKytbAd" style="width: 9%; font-weight: bold; text-align: right" title="Estimated fair value liability at beginning balance">2,214</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zJnZXCafjZO7" style="width: 9%; font-weight: bold; text-align: right" title="Estimated fair value at beginning balance">19,705</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20220101__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zK9lheTQe3Kl" style="width: 9%; font-weight: bold; text-align: right" title="Estimated fair value at beginning balance">10,373</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20210101__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_z0EVjhf2SdZb" style="width: 9%; font-weight: bold; text-align: right" title="Estimated fair value at beginning balance">-</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Estimated fair value of warrant issuance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_pn3n3_d0_c20220701__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zvpcdqfc2nzg" style="text-align: right" title="Estimated fair value of warrant issuance">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_pn3n3_d0_c20210701__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zC3Vi2Mmv5lk" style="text-align: right" title="Estimated fair value of warrant issuance">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_pn3n3_d0_c20220101__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zKHg1LvSAIn9" style="text-align: right" title="Estimated fair value of warrant issuance">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_pn3n3_c20210101__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zAfxIRt4j3Yh" style="text-align: right" title="Estimated fair value of warrant issuance">33,116</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Change in estimated fair value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_iN_pn3n3_di_c20220701__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zZdZgEoXEYO4" style="border-bottom: Black 1pt solid; text-align: right" title="Change in estimated fair value">911</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_iN_pn3n3_di_c20210701__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zkL4UJT0IIu5" style="border-bottom: Black 1pt solid; text-align: right" title="Change in estimated fair value">(2,422</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_iN_pn3n3_di_c20220101__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_ziNXvYniwog" style="border-bottom: Black 1pt solid; text-align: right" title="Change in estimated fair value">(7,248</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_iN_pn3n3_di_c20210101__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_z19MCuPGEFEk" style="border-bottom: Black 1pt solid; text-align: right" title="Change in estimated fair value">(15,833</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">Estimated fair value (end of period)</td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20220701__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zJTrsOLE8Yre" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Estimated fair value at ending balance">3,125</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zsJj7RPPRICh" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Estimated fair value at ending balance">17,283</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20220101__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zccX4LYjWsL5" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Estimated fair value at ending balance">3,125</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210101__20210930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_z7aB1S7QdSjl" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Estimated fair value at ending balance">17,283</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zVQcgZT7pfyc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Warrant Liability is remeasured to its fair value at each reporting period and upon settlement. The change in fair value is recognized in “Fair value change of warrant liability” on the unaudited condensed consolidated statements of operations.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated fair value of the Private Placement Warrants and the Working Capital Warrants (each as defined below) is determined using Level 3 inputs by using the Black-Scholes model. The application of the Black-Scholes model requires the use of a number of inputs and significant assumptions including volatility. Significant judgment is required in determining the expected volatility of our common stock. Due to the limited history of trading of our common stock, we determined expected volatility based on a peer group of publicly traded companies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following tables provide quantitative information regarding Level 3 fair value measurement inputs as of their measurement date September 30, 2022:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_pn3n3_zawWAP1dlWf2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies,Fair value measurement input (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt"><span id="xdx_8BF_zpMYyhQ5oPTk" style="display: none"><span id="xdx_8B1_z1B0j5GcdUdk" style="display: none">Fair Value Measurements Input</span></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="5" style="font-weight: bold; text-align: center">Available for Sale Financial Asset</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; text-indent: 0pt; padding-left: 0pt">Interest Rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_907_ecustom--FairValueOfAssetInterestRate_iI_pip0_dp_c20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsAssetsMember__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputInterestRateMember_z66fa5WX26pc" title="Interest Rate">8.00</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Discount Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_pip0_dp_uPure_c20220101__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsAssetsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zxfd8YDTTdql" title="Discount Rate">8.00</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Remaining term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--FinancialAssetRemainingTermInYears_dtY_c20220101__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsAssetsMember_zac4UPtLFK0a" title="Remaining term (in years)">2.75</span></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FR"> <tr style="vertical-align: bottom"> <td colspan="5" style="font-weight: bold; text-align: center">Warrant Liability</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-indent: 0pt; padding-left: 0pt">Stock price</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pip0_c20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zb9t2yRvWbF9" style="width: 9%; text-align: right" title="Stock price">3.06</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt">Exercise price (strike price)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--OptionIndexedToIssuersEquityStrikePrice1_pip0_c20220101__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zZzbfX7u9JPg" style="text-align: right" title="Exercise price (strike price)">11.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pip0_dp_c20220101__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_z9Op1xtRyNV2" title="Risk-free interest rate">4.13</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0pt; padding-left: 0pt">Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pip0_dp_c20220101__20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zqrrFCmB4FNj" title="Volatility">75.90</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Remaining term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220930__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zdFUktQ7WIz3" title="Remaining term (in years)">3.34</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A3_z5eWzQU9kf8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company performs routine procedures such as comparing prices obtained from independent source to ensure that appropriate fair values are recorded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i> </i></b></p>
CY2022Q3	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	0	usd
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	0	usd
CY2022Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2084000	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3550000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	97000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	411000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1987000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3139000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	415000	usd
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	411000	usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q3	adn	Additions To Other Assets Amounts AdditionsToOtherAssetsAmounts	-1000	usd
CY2021Q3	adn	Additions To Other Assets Amounts AdditionsToOtherAssetsAmounts	0	usd
	adn	Additions To Other Assets Amounts AdditionsToOtherAssetsAmounts	39000	usd
	adn	Additions To Other Assets Amounts AdditionsToOtherAssetsAmounts	0	usd
CY2022Q3	adn	Assumed At Business Combination AssumedAtBusinessCombination	0	usd
CY2021Q3	adn	Assumed At Business Combination AssumedAtBusinessCombination	397000	usd
	adn	Assumed At Business Combination AssumedAtBusinessCombination	0	usd
	adn	Assumed At Business Combination AssumedAtBusinessCombination	397000	usd
CY2022Q3	adn	Income From Unused Provisions IncomeFromUnusedProvisions	319000	usd
CY2021Q3	adn	Income From Unused Provisions IncomeFromUnusedProvisions	-0	usd
	adn	Income From Unused Provisions IncomeFromUnusedProvisions	319000	usd
	adn	Income From Unused Provisions IncomeFromUnusedProvisions	-0	usd
CY2022Q3	adn	Accounts Receivable Allowance For Credit Loss Foreign Exchange Fluctuations AccountsReceivableAllowanceForCreditLossForeignExchangeFluctuations	-2000	usd
CY2021Q3	adn	Accounts Receivable Allowance For Credit Loss Foreign Exchange Fluctuations AccountsReceivableAllowanceForCreditLossForeignExchangeFluctuations	-0	usd
	adn	Accounts Receivable Allowance For Credit Loss Foreign Exchange Fluctuations AccountsReceivableAllowanceForCreditLossForeignExchangeFluctuations	34000	usd
	adn	Accounts Receivable Allowance For Credit Loss Foreign Exchange Fluctuations AccountsReceivableAllowanceForCreditLossForeignExchangeFluctuations	-0	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	97000	usd
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	397000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	97000	usd
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	397000	usd
CY2022Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	7239000	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	5361000	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	555000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	757000	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3367000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	888000	usd
CY2022Q3	us-gaap	Inventory Gross InventoryGross	11161000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	7006000	usd
CY2022Q3	adn	Provision For Slow Moving Inventory ProvisionForSlowMovingInventory	228000	usd
CY2021Q4	adn	Provision For Slow Moving Inventory ProvisionForSlowMovingInventory	48000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	10933000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	6958000	usd
CY2022Q2	adn	Change In Provision For Slow Moving Inventory Balance At Beginning ChangeInProvisionForSlowMovingInventoryBalanceAtBeginning	-44000	usd
CY2021Q2	adn	Change In Provision For Slow Moving Inventory Balance At Beginning ChangeInProvisionForSlowMovingInventoryBalanceAtBeginning	-0	usd
CY2021Q4	adn	Change In Provision For Slow Moving Inventory Balance At Beginning ChangeInProvisionForSlowMovingInventoryBalanceAtBeginning	-48000	usd
CY2020Q4	adn	Change In Provision For Slow Moving Inventory Balance At Beginning ChangeInProvisionForSlowMovingInventoryBalanceAtBeginning	-0	usd
CY2022Q3	adn	Provision For Slow Moving Inventory Assumed Business Combination ProvisionForSlowMovingInventoryAssumedBusinessCombination	0	usd
CY2021Q3	adn	Provision For Slow Moving Inventory Assumed Business Combination ProvisionForSlowMovingInventoryAssumedBusinessCombination	49000	usd
	adn	Provision For Slow Moving Inventory Assumed Business Combination ProvisionForSlowMovingInventoryAssumedBusinessCombination	0	usd
	adn	Provision For Slow Moving Inventory Assumed Business Combination ProvisionForSlowMovingInventoryAssumedBusinessCombination	49000	usd
CY2022Q3	adn	Provision For Slow Moving Inventory Additions ProvisionForSlowMovingInventoryAdditions	204000	usd
CY2021Q3	adn	Provision For Slow Moving Inventory Additions ProvisionForSlowMovingInventoryAdditions	0	usd
	adn	Provision For Slow Moving Inventory Additions ProvisionForSlowMovingInventoryAdditions	204000	usd
	adn	Provision For Slow Moving Inventory Additions ProvisionForSlowMovingInventoryAdditions	0	usd
CY2022Q3	adn	Provision For Slow Moving Inventory Foreign Exchange Fluctuations ProvisionForSlowMovingInventoryForeignExchangeFluctuations	20000	usd
CY2021Q3	adn	Provision For Slow Moving Inventory Foreign Exchange Fluctuations ProvisionForSlowMovingInventoryForeignExchangeFluctuations	-0	usd
	adn	Provision For Slow Moving Inventory Foreign Exchange Fluctuations ProvisionForSlowMovingInventoryForeignExchangeFluctuations	24000	usd
	adn	Provision For Slow Moving Inventory Foreign Exchange Fluctuations ProvisionForSlowMovingInventoryForeignExchangeFluctuations	-0	usd
CY2022Q3	adn	Change In Provision For Slow Moving Inventory Balance At Beginning ChangeInProvisionForSlowMovingInventoryBalanceAtBeginning	-228000	usd
CY2021Q3	adn	Change In Provision For Slow Moving Inventory Balance At Beginning ChangeInProvisionForSlowMovingInventoryBalanceAtBeginning	-49000	usd
CY2022Q3	adn	Change In Provision For Slow Moving Inventory Balance At Beginning ChangeInProvisionForSlowMovingInventoryBalanceAtBeginning	-228000	usd
CY2021Q3	adn	Change In Provision For Slow Moving Inventory Balance At Beginning ChangeInProvisionForSlowMovingInventoryBalanceAtBeginning	-49000	usd
CY2022Q3	us-gaap	Prepaid Insurance PrepaidInsurance	946000	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	355000	usd
CY2022Q3	adn	Prepaid Research PrepaidResearch	287000	usd
CY2021Q4	adn	Prepaid Research PrepaidResearch	495000	usd
CY2022Q3	us-gaap	Prepaid Rent PrepaidRent	93000	usd
CY2021Q4	us-gaap	Prepaid Rent PrepaidRent	99000	usd
CY2022Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	331000	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	191000	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1657000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1140000	usd
CY2022Q3	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	1063000	usd
CY2021Q4	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	981000	usd
CY2022Q3	adn	Withholding Tax WithholdingTax	753000	usd
CY2021Q4	adn	Withholding Tax WithholdingTax	108000	usd
CY2022Q3	us-gaap	Grants Receivable GrantsReceivable	375000	usd
CY2021Q4	us-gaap	Grants Receivable GrantsReceivable	510000	usd
CY2022Q3	adn	Purchases Under Receipt PurchasesUnderReceipt	233000	usd
CY2021Q4	adn	Purchases Under Receipt PurchasesUnderReceipt	274000	usd
CY2022Q3	adn	Guarantees Guarantees	37000	usd
CY2021Q4	adn	Guarantees Guarantees	24000	usd
CY2022Q3	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	908000	usd
CY2021Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	2836000	usd
CY2022Q3	adn	Accrued Interest Income AccruedInterestIncome	39000	usd
CY2021Q4	adn	Accrued Interest Income AccruedInterestIncome	-0	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	3408000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4733000	usd
CY2021Q1	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	21401
CY2021Q1	adn	Design And Construction Expenses Reimbursed By Lessor DesignAndConstructionExpensesReimbursedByLessor	8000000.0	usd
CY2022Q3	adn	Design And Construction Expenses Reimbursed By Lessor DesignAndConstructionExpensesReimbursedByLessor	6500000	usd
CY2022Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	800000	usd
CY2021Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	2600000	usd
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross	30000000.0	usd
CY2022Q3	us-gaap	Goodwill Gross GoodwillGross	30000000.0	usd
CY2022Q3	us-gaap	Goodwill Goodwill	30030000	usd
	us-gaap	Indefinitelived Intangible Assets Acquired IndefinitelivedIntangibleAssetsAcquired	406000	usd
	us-gaap	Indefinitelived Intangible Assets Acquired IndefinitelivedIntangibleAssetsAcquired	406000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	24311000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3379000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20932000	usd
CY2022Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	24717000	usd
CY2022Q3	adn	Intangible Assets Gross Excluding Goodwill Accumulated Amortization IntangibleAssetsGrossExcludingGoodwillAccumulatedAmortization	3379000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	21338000	usd
CY2021	us-gaap	Indefinitelived Intangible Assets Acquired IndefinitelivedIntangibleAssetsAcquired	406000	usd
CY2021	us-gaap	Indefinitelived Intangible Assets Acquired IndefinitelivedIntangibleAssetsAcquired	406000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	24221000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1283000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22938000	usd
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	24627000	usd
CY2021Q4	adn	Intangible Assets Gross Excluding Goodwill Accumulated Amortization IntangibleAssetsGrossExcludingGoodwillAccumulatedAmortization	1283000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23344000	usd
CY2022Q3	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22938000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16132000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15166000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6387000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6581000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9745000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8585000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	800000	usd
	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	3500000	usd
CY2021Q3	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	1800000	usd
	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	2700000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	300000	usd
CY2021Q3	us-gaap	Depreciation Depreciation	500000	usd
	us-gaap	Depreciation Depreciation	1100000	usd
	us-gaap	Depreciation Depreciation	600000	usd
	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	200000	usd
CY2021Q4	adn	Executive Severance Payable ExecutiveSeverancePayable	1200000	usd
CY2022Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1719000	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	5903000	usd
CY2022Q3	adn	Other Short Term Payables Current OtherShortTermPayablesCurrent	4592000	usd
CY2021Q4	adn	Other Short Term Payables Current OtherShortTermPayablesCurrent	4590000	usd
CY2022Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	1114000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1236000	usd
CY2021Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	424000	usd
CY2022Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	195000	usd
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	208000	usd
CY2022Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	390000	usd
CY2022Q3	adn	Other Current Liabilities Social Security Funds OtherCurrentLiabilitiesSocialSecurityFunds	46000	usd
CY2021Q4	adn	Other Current Liabilities Social Security Funds OtherCurrentLiabilitiesSocialSecurityFunds	84000	usd
CY2022Q3	adn	Other Current Liabilities Overtime Provision OtherCurrentLiabilitiesOvertimeProvision	41000	usd
CY2021Q4	adn	Other Current Liabilities Overtime Provision OtherCurrentLiabilitiesOvertimeProvision	70000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8097000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12515000	usd
CY2022Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	-0	usd
CY2021Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3603000	usd
CY2022Q3	adn	Accrued Construction Fees Current AccruedConstructionFeesCurrent	446000	usd
CY2021Q4	adn	Accrued Construction Fees Current AccruedConstructionFeesCurrent	1285000	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	193000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	334000	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	137000	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	129000	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	943000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	552000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1719000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5903000	usd
CY2021Q4	adn	Business Combination Consideration Payable Cash BusinessCombinationConsiderationPayableCash	4400000	usd
CY2022Q3	adn	Business Combination Consideration Payable Cash BusinessCombinationConsiderationPayableCash	4400000	usd
CY2022Q3	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	600000	usd
CY2021Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	800000	usd
CY2022Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	800000	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1000000.0	usd
CY2022Q3	adn	Percentage Of Accrued Warranty Reserve On Sale Price Of Goods Sold PercentageOfAccruedWarrantyReserveOnSalePriceOfGoodsSold	0.08	pure
	adn	Period Of Accrued Warranty Reserve PeriodOfAccruedWarrantyReserve	P2Y
CY2022Q3	adn	Number Of Shares Authorized NumberOfSharesAuthorized	111000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	110000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5124846	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51717720	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51717720	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51253591	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51253591	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2399000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1674000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5880000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4167000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2399000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1674000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5880000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4167000	usd
CY2022Q3	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	900000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	1600000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1200000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1100000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2500000	usd
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2500000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2399000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1674000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5880000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4167000	usd
CY2021Q4	us-gaap	Guarantee Obligations Current Carrying Value GuaranteeObligationsCurrentCarryingValue	2700000	usd
CY2022Q3	us-gaap	Guarantee Obligations Current Carrying Value GuaranteeObligationsCurrentCarryingValue	0	usd
CY2021Q4	adn	Contractual Obligation Minimum Quantity ContractualObligationMinimumQuantity	21000	sqm
CY2022Q3	adn	Contractual Obligation Minimum Quantity Pieces ContractualObligationMinimumQuantityPieces	3236	electrodes
CY2022Q3	adn	Contractual Obligation Minimum Quantity Pieces ContractualObligationMinimumQuantityPieces	318400
CY2021Q4	adn	Contractual Obligation Quantity Pieces Remainder Of Fiscal Year ContractualObligationQuantityPiecesRemainderOfFiscalYear	904000	electrodes
CY2021Q4	adn	Contractual Obligation Quantity Pieces Remainder Of Fiscal Year ContractualObligationQuantityPiecesRemainderOfFiscalYear	15200000
CY2021Q4	adn	Contractual Obligation Quantity Remainder Of Fiscal Year ContractualObligationQuantityRemainderOfFiscalYear	1200000	sqm
CY2021Q4	us-gaap	Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear	970000	usd
CY2021Q4	adn	Contractual Obligation Quantity Pieces Year One ContractualObligationQuantityPiecesYearOne	1428000	electrodes
CY2021Q4	adn	Contractual Obligation Quantity Pieces Year One ContractualObligationQuantityPiecesYearOne	182400000
CY2021Q4	adn	Contractual Obligation Quantity Year One ContractualObligationQuantityYearOne	4000000	sqm
CY2021Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	3523000	usd
CY2021Q4	adn	Contractual Obligation Quantity Pieces Year Two ContractualObligationQuantityPiecesYearTwo	108000000
CY2021Q4	adn	Contractual Obligation Quantity Year Two ContractualObligationQuantityYearTwo	6000000	sqm
CY2021Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	2467000	usd
CY2021Q4	adn	Contractual Obligation Quantity Pieces Years Three ContractualObligationQuantityPiecesYearsThree	0	electrodes
CY2021Q4	adn	Contractual Obligation Quantity Pieces Years Three ContractualObligationQuantityPiecesYearsThree	0
CY2021Q4	adn	Contractual Obligation Quantity Year Three ContractualObligationQuantityYearThree	8000000	sqm
CY2021Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	1950000	usd
CY2021Q4	adn	Contractual Obligation Quantity Pieces ContractualObligationQuantityPieces	2332000	electrodes
CY2021Q4	adn	Contractual Obligation Quantity Pieces ContractualObligationQuantityPieces	305600000
CY2021Q4	adn	Contractual Obligation Quantity ContractualObligationQuantity	19200000	sqm
CY2021Q4	us-gaap	Contractual Obligation ContractualObligation	8910000	usd
CY2021Q1	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	6041
CY2021Q1	us-gaap	Capital Lease Obligations CapitalLeaseObligations	500000	usd
CY2021Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2021Q1	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	21401
CY2021Q1	us-gaap	Capital Lease Obligations CapitalLeaseObligations	1500000	usd
CY2021Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P8Y6M
CY2021Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2021Q1	us-gaap	Security Deposit SecurityDeposit	800000	usd
CY2021Q3	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	1017
CY2021Q3	adn	Operating Lease Monthly Basic Rate Plus Vat OperatingLeaseMonthlyBasicRatePlusVAT	7768	eur
CY2021Q3	us-gaap	Security Deposit SecurityDeposit	30000	eur
CY2022Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	300000	usd
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1000000.0	usd
CY2021Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	300000	usd
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	500000	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	934000	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2439000	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2309000	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2308000	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1933000	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	16425000	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	26348000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-11468000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-11280000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-26712000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11517000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51660133	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48325164	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51465004	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43982039	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51660133	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48325164	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51465004	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43982039	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26

Files In Submission

Name	View Source	Status
0001829126-22-019214-index-headers.html	Edgar Link	pending
0001829126-22-019214-index.html	Edgar Link	pending
0001829126-22-019214.txt	Edgar Link	pending
0001829126-22-019214-xbrl.zip	Edgar Link	pending
adn-20220930.xsd	Edgar Link	pending
adventtech_10q.htm	Edgar Link	pending
adn-20220930_lab.xml	Edgar Link	unprocessable
adn-20220930_def.xml	Edgar Link	unprocessable
adn-20220930_pre.xml	Edgar Link	unprocessable
adventtech_ex31-1.htm	Edgar Link	pending
adventtech_ex31-2.htm	Edgar Link	pending
adventtech_ex32-1.htm	Edgar Link	pending
adventtech_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
adventtech_10q_htm.xml	Edgar Link	completed
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
adn-20220930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ADN
ADVENT TECHNOLOGIES HOLDINGS, INC. Stock $adn

2022 Q4 Form 10-Q Financial Statement

#000182912622019214 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ADN ADVENT TECHNOLOGIES HOLDINGS, INC. Stock $adn

2022 Q4 Form 10-Q Financial Statement

#000182912622019214 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ADN
ADVENT TECHNOLOGIES HOLDINGS, INC. Stock $adn